Abbott Profit Rises on Sales of Drugs, Devices
NEW YORK (Reuters) - Abbott Laboratories Inc <ABT.N> said
on Wednesday first-quarter earnings increased 34 percent on
higher sales of its prescription drugs and medical devices and
favorable foreign exchange factors.
